טוען...
Risk of Kaposi sarcoma during the first months on combination antiretroviral therapy
OBJECTIVE: Determine if incident AIDS-defining Kaposi sarcoma (KS) or Pneumocystis jiroveci pneumonia (PJP) is associated with combination antiretroviral therapy (cART) initiation. DESIGN: Compare risk for KS and PJP by time on cART and CD4 reconstitution. METHODS: In the FHDH-ANRS CO4 cohort (N=66,...
שמור ב:
| Main Authors: | , , , , , , , , , , , , , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2013
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3623279/ https://ncbi.nlm.nih.gov/pubmed/23196937 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/QAD.0b013e32835cba6c |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|